Dovato

Dolutegravir (DTG/3TC)

Initial regimen to consider when ABC, TAF, and TDF cannot be used or are not optimal
Single-Tablet Regimen

Standard Dose

One tablet once daily, without regard to food. Tablet contains 50 mg of the INSTI dolutegravir plus 300 mg of the NRTI lamivudine.

Take missed dose as soon as possible, unless it is closer to the time of your next dose. Do not double up on your next dose. Dovato is not recommended for people with CrCl less than 50 mL/min or who have severe liver impairment.

See the individual drugs contained in this medication: Tivicay and Epivir.

See package insert for more complete information on potential side effects and interactions.

Manufacturer

ViiV Healthcare
viivhealthcare.com
(877) 844-8872

AWP

$2,754/month

Potential Side Effects and Toxicity

Potential Drug Interactions

More Information

Doctor Comments

Activist Comments